Skip to search formSkip to main contentSkip to account menu

ISIS104838

Known as: ISIS-104838 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
  • P. Kennewell
  • Current opinion in molecular therapeutics (Print)
  • 2003
  • Corpus ID: 40141364
OraSense Ltd (a joint venture between Isis Pharmaceuticals Inc and Elan Corp) is developing ISIS-104838, an antisense… 
2003
2003
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…